148 related articles for article (PubMed ID: 32647495)
1. A methylation-based mRNA signature predicts survival in patients with gastric cancer.
Li Y; Sun R; Zhang Y; Yuan Y; Miao Y
Cancer Cell Int; 2020; 20():284. PubMed ID: 32647495
[TBL] [Abstract][Full Text] [Related]
2. A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma.
Wang Y; Ruan Z; Yu S; Tian T; Liang X; Jing L; Li W; Wang X; Xiang L; Claret FX; Nan K; Guo H
Aging (Albany NY); 2019 Jan; 11(1):160-173. PubMed ID: 30631005
[TBL] [Abstract][Full Text] [Related]
3. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer.
Liu D; Ma X; Yang F; Xiao D; Jia Y; Wang Y
Cancer Gene Ther; 2020 Jun; 27(6):473-485. PubMed ID: 31308482
[TBL] [Abstract][Full Text] [Related]
5. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of DNA methylation in the efficacy of chemotherapy for gastric cancer.
Li Y; Mo N; Yang D; Lin Q; Huang W; Wang R
Front Oncol; 2023; 13():1238310. PubMed ID: 37771430
[TBL] [Abstract][Full Text] [Related]
8. A methylation-based prognostic model predicts survival in patients with colorectal cancer.
Tan S; Gui W; Wang S; Sun C; Xu X; Liu L
J Gastrointest Oncol; 2021 Aug; 12(4):1590-1600. PubMed ID: 34532113
[TBL] [Abstract][Full Text] [Related]
9. Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hong J; Chen H; Fang JY
J Cancer; 2017; 8(13):2575-2586. PubMed ID: 28900495
[TBL] [Abstract][Full Text] [Related]
10. A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer.
Li C; Zheng Y; Pu K; Zhao D; Wang Y; Guan Q; Zhou Y
Cancer Cell Int; 2020; 20():88. PubMed ID: 32206039
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
Wu ZH; Zhou T; Sun HY
Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
[TBL] [Abstract][Full Text] [Related]
12. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
[TBL] [Abstract][Full Text] [Related]
13. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma.
Wang B; Zhang Y
Open Med (Wars); 2020; 15(1):850-859. PubMed ID: 33336043
[TBL] [Abstract][Full Text] [Related]
14. Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients.
Zhou L; Chen Z; Wu Y; Lu H; Xin L
Cancer Cell Int; 2021 Jul; 21(1):357. PubMed ID: 34233659
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
16. A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Li Y; Li R; Wang X; Yuan Y; Zhang Y
Biomed Res Int; 2021; 2021():6633289. PubMed ID: 33969120
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an integrative methylation signature and nomogram for predicting survival in clear cell renal cell carcinoma.
Peng Q; Zhou Y; Jin L; Cao C; Gao C; Zhou J; Yang D; Zhu J
Transl Androl Urol; 2020 Jun; 9(3):1082-1098. PubMed ID: 32676392
[TBL] [Abstract][Full Text] [Related]
19. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
